Cough syrup case: Without the deaths of virtually 12 children in Madhya Pradesh and Rajasthan, the Tamil Nadu government has vetoed the sale of cough syrup "Coldrif" and ordered its removal from the market. Following the unfortunate incident, the sale of the cough syrup, manufactured by the Chennai-based company, has been vetoed in Tamil Nadu.
Amid the cough syrup controversy, drug tenancy officials from Delhi and Chennai inspected a manufacturing unit at a pharmaceutical plant in Kanchipuram. Meanwhile, the Rajasthan government has suspended the state drug controller and vetoed the sale of drugs manufactured by Jaipur-based visitor Kaysons Pharma.
Sale of 'Coldrif' cough syrup vetoed in Tamil Nadu
The Tamil Nadu government has vetoed the sale of the cough syrup "Coldriff." An order has moreover been issued to remove it from the market. The Food Safety Department stated that its manufacture and sale is completely prohibited in the state from October 1. The manufacturing unit in Kanchipuram district was inspected and samples were collected. The visitor has been vetoed from producing the syrup until the government lab reports the results of testing.
It is to be noted here that the pharmaceutical company, located in Sunguvarachatram, Kanchipuram district, supplies medicines to Rajasthan, Madhya Pradesh, and Puducherry. Without the death of 12 children in Madhya Pradesh and Rajasthan, the Tamil Nadu government has vetoed the sale of the cough syrup "Coldrif."
Measures taken by Rajasthan govt
Rajasthan government has moreover taken strict whoopee in connection with the 'Coldrif' cough syrup. The Rajasthan government has suspended the drug controller and halted the distribution of medicines manufactured by Jaipur-based visitor Kesons Pharma. Officials said the Medical and Health Department has vetoed the supply of all 19 medicines manufactured by Kesons Pharma until remoter orders. Distribution of all other cough syrups containing dextromethorphan has been banned.
Instructions Issued by Health Ministry
Taking conversance of the child deaths, the Union Health Ministry on Friday issued a directive to all states and union territories, stating that cough and unprepossessed medicines should not be given to children unelevated the age of two. The directive, issued by the Directorate General of Health Services, comes without the deaths of children in Madhya Pradesh and Rajasthan due to tangibly contaminated cough syrup.
Allegations of mixing restriction oil solvent in cough syrup
Senior Madhya Pradesh Congress leader Kamal Nath has blamed that "brake oil solvent" was mixed into the cough syrup causing the death of children. The Health Ministry has ordered the visitor to halt production of the syrup at its facility until laboratory reports are received.
